Axsome Therapeutics (AXSM) Intangibles (2022 - 2026)
Axsome Therapeutics' Intangibles came in at $37.36 million for Q2 2026, down 14.6% from $43.73 million a year earlier and down 4.1% from the prior quarter.
Powered by 
Analysis
Axsome Therapeutics (AXSM) Intangibles (2022 - 2026) Analysis & Trends
At the end of FY2025, Axsome Therapeutics' Intangibles was $40.52 million, down 13.6% from FY2024.
- Intangibles has declined in each of the last three years, with a three-year compound annual growth rate of -12.1% (FY2022 to FY2025).
- Going back by year, Intangibles was $46.89 million in FY2024 (-12.0%), $53.29 million in FY2023 (-10.7%) and $59.66 million in FY2022.
- The Q2 2026 figure represents the lowest quarterly Intangibles in data going back to Q2 2022.
- Year-over-year, Intangibles has declined for 13 consecutive quarters, with an average decline of 13.0% over the last eight quarters.
- Across the past five years, year-over-year decline in Intangibles ran from 10.1% in Q2 2023 to 14.6% in Q2 2026.
- Business Quant data shows AXSM's Intangibles at $38.95 million (Q1 2026), $40.52 million (Q4 2025) and $42.13 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 48.23 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 49.14 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 24.98 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 42.07 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | 37.72 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 20.49 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 14.03 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 47.05 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 412.80 Mn |
| 10 | Axsome Therapeutics | 9.64 Bn | 8.37 Bn | 204.81 Mn | 37.36 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 37.36 Mn |
| Mar 31, 2026 | 38.95 Mn |
| Dec 31, 2025 | 40.52 Mn |
| Sep 30, 2025 | 42.13 Mn |
| Jun 30, 2025 | 43.73 Mn |
| Mar 31, 2025 | 45.32 Mn |
| Dec 31, 2024 | 46.89 Mn |
| Sep 30, 2024 | 48.50 Mn |
| Jun 30, 2024 | 50.11 Mn |
| Mar 31, 2024 | 51.70 Mn |
| Dec 31, 2023 | 53.29 Mn |
| Sep 30, 2023 | 54.89 Mn |
| Jun 30, 2023 | 56.50 Mn |
| Mar 31, 2023 | 58.09 Mn |
| Dec 31, 2022 | 59.66 Mn |
| Sep 30, 2022 | 61.27 Mn |
| Jun 30, 2022 | 62.87 Mn |
API Access
Axsome Therapeutics Intangibles API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=intangibles&ticker=AXSM&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "intangibles", "ticker": "AXSM", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=intangibles&ticker=AXSM&period=max&api_key=YOUR_API_KEY");
const data = await res.json();